Tao Fu
2017
In 2017, Tao Fu earned a total compensation of $2.4M as Executive Vice President, Chief Commercial and Business Officer at Portola Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $222,381 |
|---|---|
| Option Awards | $959,013 |
| Salary | $411,817 |
| Stock Awards | $798,125 |
| Other | $8,100 |
| Total | $2,399,436 |
Fu received $959K in option awards, accounting for 40% of the total pay in 2017.
Fu also received $222.4K in non-equity incentive plan, $411.8K in salary, $798.1K in stock awards and $8.1K in other compensation.
Rankings
In 2017, Tao Fu's compensation ranked 4,644th out of 14,666 executives tracked by ExecPay. In other words, Fu earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,644 out of 14,666 | 68th |
Division Manufacturing | 1,634 out of 5,768 | 72nd |
Major group Chemicals And Allied Products | 475 out of 2,074 | 77th |
Industry group Drugs | 367 out of 1,730 | 79th |
Industry Pharmaceutical Preparations | 290 out of 1,329 | 78th |
Source: SEC filing on April 24, 2018.
Fu's colleagues
We found four more compensation records of executives who worked with Tao Fu at Portola Pharmaceuticals in 2017.